Trials / Completed
CompletedNCT02543034
Compare of Petrolatum Gauze, Allevyn, and New Dressing, Betafoam® in the Management of Split-Thickness Skin Graft Donor Site
Randomized, Controlled, Phase IV Study of Petrolatum Gauze, Allevyn, and New Dressing, Betafoam® in the Management of Split-Thickness Skin Graft Donor Site
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Mundipharma Korea Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is a randomized, controlled, multi-centre, open-label, phase IV study. Total 81 patients will be enrolled in this study. Patients will be randomly assigned to Betafoam®, petrolatum gauze or Allevyn for donor site wounds after skin graft operation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Betafoam Wound Dressing | Foam dressing including Betadine iodine |
| DEVICE | Petrolatum Gauze | Gauze dressing |
| DEVICE | Allevyn Wound Dressing | Foam dressing |
Timeline
- Start date
- 2016-03-16
- Primary completion
- 2017-04-14
- Completion
- 2017-05-01
- First posted
- 2015-09-07
- Last updated
- 2017-11-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02543034. Inclusion in this directory is not an endorsement.